Showing 91-100 of 1407 results for "".
Parkinson's Study Looks for Prodromal and Disease Progression Biomarkers
https://practicalneurology.com/columns/practice-management/parkinsons-study-looks-for-prodromal-and-disease-progression-biomarkers/30710/WEB FIRST LOOK: A Summary by the Parkinson's Progression Marker's Initiative*Movement Disorders Focus: Empowering Patients by Being a Team Player
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/empowering-patients-by-being-a-team-player/30625/By arming patients with the resources they need to make informed decisions about their own care, we can be true teammates on their roster of health care professionals.MS Minute: Ibudilast
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-ibudilast/31622/Ibudilast is a phosphodiesterase inhibitor that has shown some benefit for progressive multiple sclerosis in a phase 2 trial.Amyotrophic Lateral Sclerosis with Atrophy of the Amygdala
https://practicalneurology.com/diseases-diagnoses/neuromuscular/amyotrophic-lateral-sclerosis-with-atrophy-of-the-amygdala/30444/Early and pronounced involvement of the amygdala is known to be characteristic for the behavioral variant of frontotemporal dementia, but it may also occur in ALS.Parry-Romberg Syndrome With Drug-Resistant Epilepsy
https://practicalneurology.com/diseases-diagnoses/child-neurology/parry-romberg-syndrome-with-drug-resistant-epilepsy/31841/En coup de epilepsie—seizures, headaches, and imaging findings ipsilateral to cutaneous manifestations.Teleneuro-ophthalmology
https://practicalneurology.com/diseases-diagnoses/headache-pain/teleneuro-ophthalmology/31670/Something can almost always be offered virtually for people with neuro-ophthalmologic conditions.Pharmacology of Emerging Selective Sodium Channel Antagonists for the Treatment of Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pharmacology-of-emerging-selective-sodium-channel-antagonists-for-the-treatment-of-epilepsy/39904/The development of isoform-selective sodium channel inhibitors that spare GABAergic interneuron function is in its early stages but holds promise as an exciting area of research.Multiple Sclerosis Minute: Telemedicine and Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-telemedicine-and-multiple-sclerosis/30116/Telemedicine is acceptable to patients and clinicians in the continuum of clinic-to-in-home care and reduces barriers to care.Diagnosis and Management of Neurodegenerative Atypical Parkinsonism
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-neurodegenerative-atypical-parkinsonism/30455/Movement Disorders Focus: Harnessing Existing Drugs to Slow Progression of Parkinson's Disease: The STEADY-PDIII Trial of Isradipine
https://practicalneurology.com/diseases-diagnoses/movement-disorders/harnessing-existing-drugs-to-slow-progression-of-parkinsons-disease-the-steady-pdiii-trial-of-isradipine/30654/